The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival
about
WEE1 kinase polymorphism as a predictive biomarker for efficacy of platinum-gemcitabine doublet chemotherapy in advanced non-small cell lung cancer patients.Caspase 8 polymorphisms contribute to the prognosis of advanced lung adenocarcinoma patients after platinum-based chemotherapy.MicroRNA-1468-5p inhibits glioma cell proliferation and induces cell cycle arrest by targeting RRM1.ERCC1 single nucleotide polymorphism C8092A, but not its expression is associated with survival of esophageal squamous cell carcinoma patients from Fujian province, China.ERCC1, RRM1 and TUBB3 mRNA expression on the tumor response and overall survival of non-small cell lung cancer treated with platinum-based chemotherapyDrug sensitivity profiling and molecular characteristics of cells from pleural effusions of patients with lung adenocarcinoma.Variation in the expression levels of predictive chemotherapy biomarkers in histological subtypes of lung adenocarcinoma: an immunohistochemical study of tissue samplesExpression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I-III Non-Small Cell Lung Cancer.Association of CDC25 phosphatase family polymorphisms with the efficacy/toxicity of platinum-based chemotherapy in Chinese advanced NSCLC patients.Prognostic value of ERCC1, RRM1, BRCA1 and SETDB1 in early stage of non-small cell lung cancer.Prognostic value of ERCC1, RRM1, and TS proteins in patients with resected non-small cell lung cancer.ERCC1_202 Is A Prognostic Biomarker in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy.ERCC1 and BRCA1 mRNA expressions are associated with clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy.ERCC1 Expression-Based Randomized Phase II Study of Gemcitabine/Cisplatin Versus Irinotecan/Cisplatin in Patients with Advanced Non-small Cell Lung Cancer.
P2860
Q27853174-FD582AD6-CB87-4FF3-A46A-A09B0815A7C6Q33439990-70DB77C2-FB90-4CB0-8125-62C743D78BF1Q33622651-15B6E624-FDD2-4011-A53D-F38B7CAEEF2FQ34142322-04B0C1E0-D4BF-4C6B-A7A1-A6DBAE8D5C4BQ35061055-DFEC0C13-1E55-4192-BBB1-95031B9F461CQ35591895-D6A91525-97F3-4F61-80FF-89F710B7858CQ36261427-A792CCE5-135F-4120-81EB-6D9BF86300C4Q36333164-6F81E7CE-0174-4254-A6BB-EBC7B6988ED5Q39173149-2E95035A-1445-4538-85FC-F9C44F3611C4Q41145853-572467B3-3199-4AA0-8AD3-AE27666D3227Q41318869-3EDB3732-A6B7-4921-B384-99F53D37449CQ41721741-84324A80-61CE-40DC-B529-8924FF97B076Q44876602-9702FC53-0F42-418A-9637-5CF0E07DC180Q49516678-FBA654FA-2298-49C3-B678-F347CA6D8DED
P2860
The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The prognostic value of ERCC1 ...... ecurrence and overall survival
@en
The prognostic value of ERCC1 ...... currence and overall survival.
@nl
type
label
The prognostic value of ERCC1 ...... ecurrence and overall survival
@en
The prognostic value of ERCC1 ...... currence and overall survival.
@nl
prefLabel
The prognostic value of ERCC1 ...... ecurrence and overall survival
@en
The prognostic value of ERCC1 ...... currence and overall survival.
@nl
P2093
P2860
P356
P1476
The prognostic value of ERCC1 ...... ecurrence and overall survival
@en
P2093
Choosak Kasemsarn
Jayanton Patumanond
Nirush Lertprasertsuke
Nuttapon Arayawudhikul
Somcharoen Saeteng
P2860
P304
P356
10.2147/CMAR.S52073
P407
P577
2013-10-03T00:00:00Z